PT  - JOURNAL ARTICLE
AU  - Mieskolainen, M.
AU  - Bainbridge, R.
AU  - Buchmueller, O.
AU  - Lyons, L.
AU  - Wardle, N.
TI  - Statistical techniques to estimate the SARS-CoV-2 infection fatality rate
AID  - 10.1101/2020.11.19.20235036
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.19.20235036
4099  - http://medrxiv.org/content/early/2020/11/22/2020.11.19.20235036.short
4100  - http://medrxiv.org/content/early/2020/11/22/2020.11.19.20235036.full
AB  - The determination of the infection fatality rate (IFR) for the novel SARS-CoV-2 coronavirus is a key aim for many of the field studies that are currently being undertaken in response to the pandemic. The IFR together with the basic reproduction number R0, are the main epidemic parameters describing severity and transmissibility of the virus, respectively. The IFR can be also used as a basis for estimating and monitoring the number of infected individuals in a population, which may be subsequently used to inform policy decisions relating to public health interventions and lockdown strategies. The interpretation of IFR measurements requires the calculation of confidence intervals. We present a number of statistical methods that are relevant in this context and develop an inverse problem formulation to determine correction factors to mitigate time-dependent effects that can lead to biased IFR estimates. We also review a number of methods to combine IFR estimates from multiple independent studies, provide example calculations throughout this note and conclude with a summary and “best practice” recommendations. The developed code is available online.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and code are available online. https://github.com/mieskolainen/covidgen